Credit Suisse Likes Texas Instruments, AstraZeneca a Top Long Play, Mead Johnson Neutral
Texas Instruments Inc. (NYSE:TXN): Credit Suisse said Texas Instruments is one of the best leveraged plays in the group and reiterates its Outperform rating following the Q4 beat.
Semtech Corp. (NASDAQ:SMTC): After Semtech agreed to acquire Gennum Corp. for about $494M, Oppenheimer says that “at first glance,” the deal appears to be synergistic, strategic, and significantly accretive. The firm maintains an Outperform rating on Semtech.
AstraZeneca PLC (NYSE:AZN): AstraZeneca named a long Research Tactical Idea at Morgan Stanley
Sanofi-Aventis(NYSE:SNY): Sanofi named a long Research Tactical Idea at Morgan Stanley
Mead Johnson Nutrition Company (NYSE:MJN): Citigroup expects Mead Johnson to report in-line Q4 results on January 26 but believes the 2012 consensus estimate of $3.18 is aggressive. The firm expects the company’s guidance to come in below consensus and finds the stock expensive at current levels. Citi reiterates a Neutral rating on Mead Johnson shares.
Want news like this in real-time so you can get an edge? Click here for Wall St. Cheat Sheet Pro.